{"id":584,"date":"2026-02-28T12:39:07","date_gmt":"2026-02-28T12:39:07","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/implantable-cardioverter-defibrillator-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T12:39:07","modified_gmt":"2026-02-28T12:39:07","slug":"implantable-cardioverter-defibrillator-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/implantable-cardioverter-defibrillator-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"Implantable Cardioverter Defibrillator: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Implantable Cardioverter Defibrillator Introduction (What it is)<\/h2>\n\n\n\n<p>An Implantable Cardioverter Defibrillator is a device placed in the body to detect and treat dangerous heart rhythms.<br\/>\nIt is a therapeutic cardiac implantable electronic device used in electrophysiology and heart failure care.<br\/>\nIt is commonly encountered when assessing risk of sudden cardiac death from ventricular arrhythmias.<br\/>\nIt may also provide pacing support in selected patients, depending on device type and programming.  <\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Implantable Cardioverter Defibrillator matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Ventricular tachycardia (VT) and ventricular fibrillation (VF) are rhythm disturbances that can rapidly reduce cardiac output and lead to sudden cardiac death. An Implantable Cardioverter Defibrillator (often abbreviated ICD after first mention) is designed to recognize these rhythms and deliver therapy\u2014typically a high-energy shock (defibrillation) or anti-tachycardia pacing (ATP)\u2014to restore a more stable rhythm.<\/p>\n\n\n\n<p>For learners, the ICD sits at the intersection of physiology (how rhythm sustains cardiac output), pathology (why myocardial disease predisposes to VT\/VF), and clinical reasoning (who benefits from device therapy). In clinical practice, ICD decisions often involve risk stratification rather than symptom relief alone: many candidates feel well but have structural heart disease or inherited arrhythmia risk that elevates the chance of lethal ventricular arrhythmias.<\/p>\n\n\n\n<p>ICDs also influence longitudinal care planning. They require follow-up, programming adjustments, and attention to complications such as inappropriate shocks or device infection. Understanding ICDs helps trainees interpret device reports, manage post-implant symptoms, coordinate peri-procedural planning for other surgeries, and communicate clearly about what the device can and cannot do.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>ICDs can be categorized by <strong>lead configuration<\/strong>, <strong>pacing capability<\/strong>, and <strong>clinical role<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Transvenous ICD (TV-ICD)<\/strong><\/li>\n<li>A generator is typically placed under the skin of the upper chest.<\/li>\n<li>One or more leads are placed through the venous system into the heart (commonly the right ventricle, sometimes the right atrium).<\/li>\n<li>\n<p>Variants include:<\/p>\n<ul>\n<li><strong>Single-chamber ICD<\/strong> (typically right ventricular lead)<\/li>\n<li><strong>Dual-chamber ICD<\/strong> (right atrial and right ventricular leads), often used when atrial sensing\/pacing is helpful for rhythm discrimination or bradycardia support<\/li>\n<li><strong>Cardiac resynchronization therapy defibrillator (CRT-D)<\/strong>, which combines ICD functions with biventricular pacing for selected patients with heart failure and electrical dyssynchrony<\/li>\n<\/ul>\n<\/li>\n<li>\n<p><strong>Subcutaneous ICD (S-ICD)<\/strong><\/p>\n<\/li>\n<li>The generator is placed under the skin on the lateral chest wall, and the lead is tunneled under the skin along the sternum.<\/li>\n<li>It avoids transvenous leads and intracardiac hardware.<\/li>\n<li>\n<p>It generally <strong>does not provide chronic pacing<\/strong> for bradycardia or resynchronization and has limited pacing options for terminating VT compared with many transvenous systems.<\/p>\n<\/li>\n<li>\n<p><strong>Clinical prevention category<\/strong><\/p>\n<\/li>\n<li><strong>Secondary prevention ICD<\/strong>: placed after a patient has experienced sustained VT\/VF or resuscitated cardiac arrest thought to be due to a ventricular arrhythmia.<\/li>\n<li><strong>Primary prevention ICD<\/strong>: placed to reduce risk of sudden cardiac death in patients with elevated risk based on underlying disease characteristics, even if they have not had VT\/VF.<\/li>\n<\/ul>\n\n\n\n<p>Exact device selection depends on anatomy, rhythm needs, comorbidities, and local practice patterns; it varies by clinician and case.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>ICD function is tightly linked to cardiac anatomy and the heart\u2019s electrical conduction system:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cardiac chambers and output<\/strong><\/li>\n<li>The ventricles generate forward blood flow. Sustained VT or VF can reduce effective ventricular contraction and drop cardiac output, sometimes within seconds.<\/li>\n<li>\n<p>Symptoms and severity reflect how quickly output falls and whether the rhythm degenerates into VF.<\/p>\n<\/li>\n<li>\n<p><strong>Conduction system<\/strong><\/p>\n<\/li>\n<li>The sinoatrial (SA) node initiates normal sinus rhythm.<\/li>\n<li>The atrioventricular (AV) node and His\u2013Purkinje system coordinate rapid conduction to ventricular myocardium.<\/li>\n<li>\n<p>Ventricular arrhythmias often arise from <strong>scar-related reentry<\/strong> (e.g., prior myocardial infarction) or <strong>myocardial disease<\/strong> that alters conduction and refractoriness (e.g., dilated cardiomyopathy).<\/p>\n<\/li>\n<li>\n<p><strong>Myocardial substrate and coronary circulation<\/strong><\/p>\n<\/li>\n<li>Ischemia, infarction, inflammation, and fibrosis can create regions of slow conduction and unidirectional block, favoring reentrant VT.<\/li>\n<li>\n<p>Acute ischemia can trigger ventricular ectopy and polymorphic VT\/VF by altering ionic currents and creating dispersion of repolarization.<\/p>\n<\/li>\n<li>\n<p><strong>Device\u2013tissue interface<\/strong><\/p>\n<\/li>\n<li>Transvenous leads sense intracardiac electrical signals and can deliver pacing or shock energy through electrodes in contact with endocardium.<\/li>\n<li>Subcutaneous systems sense cardiac signals through subcutaneous electrodes, which changes signal characteristics and requires careful sensing configuration to reduce oversensing.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>An ICD does not prevent the underlying disease that causes arrhythmias; instead, it provides <strong>detection and termination<\/strong> of malignant ventricular rhythms.<\/p>\n\n\n\n<p>Core operational steps include:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>\n<p><strong>Sensing<\/strong>\n   &#8211; The device continuously monitors cardiac electrical activity.\n   &#8211; Algorithms classify rhythms based on rate, regularity, onset, and morphology patterns. These features help distinguish VT\/VF from supraventricular tachycardias (such as atrial fibrillation with rapid conduction), but discrimination is imperfect.<\/p>\n<\/li>\n<li>\n<p><strong>Detection and decision-making<\/strong>\n   &#8211; Devices are programmed with therapy \u201czones\u201d (conceptually: ranges of fast rhythms) and logic to decide whether to treat.\n   &#8211; Detection is designed to avoid treating brief, self-terminating episodes while still responding quickly to sustained VT\/VF. Specific programming strategies vary by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Therapy delivery<\/strong>\n   &#8211; <strong>Anti-tachycardia pacing (ATP)<\/strong>: rapid pacing sequences may interrupt reentrant VT without a shock. This is more typical for monomorphic VT in transvenous systems.\n   &#8211; <strong>Cardioversion\/defibrillation shocks<\/strong>: higher-energy therapy depolarizes a critical mass of myocardium to terminate VT\/VF and allow organized rhythm to resume.\n   &#8211; <strong>Bradycardia pacing<\/strong> (in many transvenous ICDs and CRT-D systems): supports slow heart rates, which may occur due to intrinsic conduction disease or as a consequence of medications used to reduce arrhythmia risk.<\/p>\n<\/li>\n<li>\n<p><strong>Data storage and communication<\/strong>\n   &#8211; Devices record electrograms and episode logs that clinicians review during in-clinic interrogation or remote monitoring.\n   &#8211; Episode review is clinically important because not every delivered therapy reflects true VT\/VF (e.g., inappropriate shocks due to oversensing or supraventricular rhythms).<\/p>\n<\/li>\n<\/ol>\n\n\n\n<p>Because devices are programmable and patient substrates differ, performance and therapy patterns can be variable.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>Common clinical scenarios where an ICD is considered include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Survivors of cardiac arrest<\/strong> due to VT\/VF after reversible causes have been evaluated and addressed<\/li>\n<li><strong>Sustained ventricular tachycardia<\/strong>, especially if hemodynamically significant or associated with structural heart disease<\/li>\n<li><strong>Reduced left ventricular systolic function<\/strong> from ischemic or nonischemic cardiomyopathy with elevated risk of sudden cardiac death (primary prevention context)<\/li>\n<li><strong>Inherited arrhythmia syndromes<\/strong> with increased risk of malignant ventricular arrhythmias (e.g., certain channelopathies), when risk is judged high<\/li>\n<li><strong>Cardiomyopathies associated with ventricular arrhythmia risk<\/strong>, such as hypertrophic cardiomyopathy or arrhythmogenic cardiomyopathy, in selected risk profiles<\/li>\n<li><strong>Patients needing resynchronization therapy<\/strong> (biventricular pacing) who also meet criteria for defibrillator capability (CRT-D vs CRT-P selection varies)<\/li>\n<\/ul>\n\n\n\n<p>Indications are typically guided by professional society recommendations and individualized risk assessment; they vary by clinician and case.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>ICD care involves two related evaluations: (1) assessing whether a patient is likely to benefit from an ICD, and (2) interpreting device function once implanted.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Pre-implant evaluation (risk and substrate assessment)<\/h3>\n\n\n\n<p>Clinicians commonly integrate:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>History and clinical context<\/strong><\/li>\n<li>Syncope, palpitations, prior sustained VT\/VF, family history of sudden cardiac death, medication exposures, and comorbid conditions.<\/li>\n<li><strong>Electrocardiogram (ECG)<\/strong><\/li>\n<li>Baseline conduction abnormalities, evidence of prior infarction, repolarization patterns suggestive of channelopathies, and rhythm documentation.<\/li>\n<li><strong>Echocardiography<\/strong><\/li>\n<li>Ventricular size and function, valvular disease, and overall structural substrate.<\/li>\n<li><strong>Ischemia and coronary evaluation<\/strong><\/li>\n<li>Depending on presentation, clinicians may assess for coronary artery disease and ischemia because active ischemia can be a reversible trigger for VT\/VF.<\/li>\n<li><strong>Ambulatory monitoring<\/strong><\/li>\n<li>Detection of nonsustained VT, atrial arrhythmias, or bradycardia patterns relevant to device choice and programming.<\/li>\n<li><strong>Cardiac magnetic resonance imaging (MRI) in selected cases<\/strong><\/li>\n<li>Assessment of scar\/fibrosis patterns that can correlate with arrhythmia risk and inform ablation planning. Feasibility depends on device status and institutional protocols.<\/li>\n<li><strong>Electrophysiology (EP) study in selected scenarios<\/strong><\/li>\n<li>Used in some contexts to clarify arrhythmia mechanism or inducibility; its role varies by protocol and patient factors.<\/li>\n<li><strong>Genetic testing and family evaluation<\/strong><\/li>\n<li>Considered when inherited arrhythmia syndromes or cardiomyopathies are suspected; interpretation is nuanced and often multidisciplinary.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Post-implant evaluation (device interrogation and interpretation)<\/h3>\n\n\n\n<p>Key concepts in ICD interpretation include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Appropriate vs inappropriate therapy<\/strong><\/li>\n<li>\u201cAppropriate\u201d therapy corresponds to true VT\/VF episodes.<\/li>\n<li>\u201cInappropriate\u201d shocks can occur from atrial arrhythmias, oversensing (e.g., T-wave oversensing), lead malfunction, or electromagnetic interference.<\/li>\n<li><strong>Lead performance<\/strong><\/li>\n<li>Sensing integrity, pacing thresholds (if applicable), and impedance trends help detect dislodgement, fracture, insulation issues, or connector problems.<\/li>\n<li><strong>Battery status and capacitor function<\/strong><\/li>\n<li>Generator longevity depends on pacing burden, shocks delivered, and device settings.<\/li>\n<li><strong>Programming review<\/strong><\/li>\n<li>Clinicians may adjust detection criteria, therapy zones, ATP strategies, and discrimination algorithms to balance safety with shock minimization.<\/li>\n<li><strong>Remote monitoring<\/strong><\/li>\n<li>Many systems support remote transmissions to flag arrhythmia episodes, lead alerts, and device status changes between clinic visits.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>An ICD is one component of a broader strategy to reduce arrhythmic death and manage the underlying cardiac disease. Management typically includes the following layers, tailored to the patient\u2019s diagnosis and goals of care.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Treat the underlying substrate and triggers<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Heart failure therapy optimization<\/strong><\/li>\n<li>For cardiomyopathy-related risk, guideline-directed medical therapy for heart failure can improve symptoms and may reduce arrhythmia burden in some patients.<\/li>\n<li><strong>Ischemia management<\/strong><\/li>\n<li>Revascularization or anti-ischemic therapy may be relevant when ischemia contributes to ventricular arrhythmias.<\/li>\n<li><strong>Address reversible contributors<\/strong><\/li>\n<li>Electrolyte disturbances, medication proarrhythmia, acute illness, and substance exposures can influence ventricular arrhythmia risk.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Device therapy pathway<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Shared decision-making and goal alignment<\/strong><\/li>\n<li>ICDs are primarily intended to prevent sudden arrhythmic death. They do not address all causes of mortality in cardiomyopathy and do not prevent progressive pump failure.<\/li>\n<li>\n<p>Discussion often includes expected benefits, potential burdens (including shocks), and alternatives; the details vary by clinician and case.<\/p>\n<\/li>\n<li>\n<p><strong>Implantation procedure (high level)<\/strong><\/p>\n<\/li>\n<li>Performed in a procedural suite under sterile conditions.<\/li>\n<li>Transvenous systems require venous access and intracardiac lead placement; subcutaneous systems avoid intravascular leads but require careful sensing setup.<\/li>\n<li>\n<p>Peri-procedural antibiotics and anticoagulation management vary by protocol and patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Programming and follow-up<\/strong><\/p>\n<\/li>\n<li>Initial programming aims to treat dangerous rhythms while reducing unnecessary shocks.<\/li>\n<li>Follow-up includes wound checks early after implant and periodic interrogation thereafter, often supplemented by remote monitoring.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Adjunct arrhythmia management<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Antiarrhythmic drugs<\/strong><\/li>\n<li>May be used to reduce VT burden and ICD therapies in selected patients, especially those with recurrent episodes.<\/li>\n<li><strong>Catheter ablation<\/strong><\/li>\n<li>Considered for recurrent monomorphic VT, electrical storm, or when drug therapy is limited by side effects or incomplete control. Timing and indications vary by protocol and patient factors.<\/li>\n<li><strong>Management of atrial arrhythmias<\/strong><\/li>\n<li>Atrial fibrillation and other supraventricular tachycardias can increase inappropriate therapies and symptoms; controlling these rhythms can improve ICD performance in practice.<\/li>\n<\/ul>\n\n\n\n<p>Importantly, ICDs complement\u2014rather than replace\u2014disease-specific treatment and longitudinal cardiovascular care.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>ICD risks depend on patient factors, device type, and operator experience. Commonly discussed issues include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Peri-procedural complications<\/strong><\/li>\n<li>Bleeding or pocket hematoma<\/li>\n<li>Pneumothorax or hemothorax (more associated with transvenous access)<\/li>\n<li>Cardiac perforation or pericardial effusion (transvenous lead placement risk)<\/li>\n<li>\n<p>Acute lead dislodgement<\/p>\n<\/li>\n<li>\n<p><strong>Infection<\/strong><\/p>\n<\/li>\n<li>\n<p>Pocket infection or systemic infection involving leads can occur and may require prolonged antibiotics and, in some cases, device extraction; risk varies by patient factors.<\/p>\n<\/li>\n<li>\n<p><strong>Lead-related problems (transvenous systems)<\/strong><\/p>\n<\/li>\n<li>Lead fracture, insulation failure, or venous occlusion<\/li>\n<li>Tricuspid valve interaction with right-sided leads in some patients<\/li>\n<li>\n<p>Long-term lead management is a major consideration because leads can be difficult to remove once chronically implanted.<\/p>\n<\/li>\n<li>\n<p><strong>Inappropriate shocks<\/strong><\/p>\n<\/li>\n<li>Can result from supraventricular tachycardias, oversensing, or device\/lead malfunction.<\/li>\n<li>\n<p>These events can cause pain, anxiety, and additional healthcare utilization.<\/p>\n<\/li>\n<li>\n<p><strong>Appropriate shocks and psychological impact<\/strong><\/p>\n<\/li>\n<li>\n<p>Even when appropriate, shocks can be distressing and may affect quality of life. Supportive counseling and device reprogramming strategies may help in selected cases.<\/p>\n<\/li>\n<li>\n<p><strong>Device limitations<\/strong><\/p>\n<\/li>\n<li>Subcutaneous ICDs generally lack chronic pacing and resynchronization, limiting use in patients who need those functions.<\/li>\n<li>\n<p>ICDs do not prevent all causes of sudden death (e.g., severe bradyarrhythmia\/asystole in some contexts) and do not treat non-arrhythmic causes of collapse.<\/p>\n<\/li>\n<li>\n<p><strong>Electromagnetic interference and procedural planning<\/strong><\/p>\n<\/li>\n<li>Certain environments and procedures can interfere with sensing or therapy delivery. Management protocols vary by institution and device manufacturer.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Prognosis in patients with an ICD is driven primarily by the <strong>underlying heart disease<\/strong>, not the device alone. An ICD can reduce death from malignant ventricular arrhythmias in appropriately selected patients, but it does not reverse cardiomyopathy, ischemic burden, or systemic comorbidities that influence overall survival.<\/p>\n\n\n\n<p>Follow-up considerations commonly include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Arrhythmia burden trends<\/strong><\/li>\n<li>Recurrent VT\/VF episodes (with ATP or shocks) often prompt reassessment for triggers, medication optimization, or ablation evaluation.<\/li>\n<li>\n<p>An episode review helps distinguish true ventricular arrhythmias from inappropriate detections.<\/p>\n<\/li>\n<li>\n<p><strong>Device surveillance<\/strong><\/p>\n<\/li>\n<li>Routine interrogations and remote monitoring can identify lead issues, battery depletion trends, and programming opportunities.<\/li>\n<li>\n<p>Generator replacement is anticipated when battery nears end of service; timing varies by device usage and settings.<\/p>\n<\/li>\n<li>\n<p><strong>Comorbidity management<\/strong><\/p>\n<\/li>\n<li>\n<p>Heart failure progression, renal disease, diabetes, sleep-disordered breathing, and ongoing ischemia can affect arrhythmia risk and overall outcomes.<\/p>\n<\/li>\n<li>\n<p><strong>Patient-centered considerations<\/strong><\/p>\n<\/li>\n<li>Quality of life, symptom burden, psychological response to shocks, and goals-of-care discussions are relevant over time.<\/li>\n<li>In advanced illness, clinicians may discuss device management choices aligned with patient goals; specifics vary by clinician and case.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Implantable Cardioverter Defibrillator Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does an Implantable Cardioverter Defibrillator actually do?<\/strong><br\/>\nIt continuously monitors heart rhythm and is designed to treat certain dangerous fast rhythms from the ventricles. Depending on the rhythm detected, it may deliver anti-tachycardia pacing or a shock to restore a more stable rhythm. Many devices also provide pacing support for slow heart rates.<\/p>\n\n\n\n<p><strong>Q: Is an ICD the same thing as a pacemaker?<\/strong><br\/>\nThey overlap but are not the same. Pacemakers primarily treat slow rhythms (bradycardia) by pacing the heart. ICDs are built to detect and treat life-threatening ventricular tachyarrhythmias, and many ICDs also include pacemaker functions.<\/p>\n\n\n\n<p><strong>Q: What conditions commonly lead to ICD placement?<\/strong><br\/>\nCommon contexts include prior sustained VT\/VF or resuscitated cardiac arrest, cardiomyopathy with reduced pumping function, and selected inherited arrhythmia syndromes. Some patients receive a combined resynchronization and defibrillation device (CRT-D) when heart failure and electrical dyssynchrony are present. Final selection depends on individualized risk assessment.<\/p>\n\n\n\n<p><strong>Q: What does it feel like when the ICD delivers therapy?<\/strong><br\/>\nAnti-tachycardia pacing may not be felt or may feel like fluttering or palpitations. A shock is often described as sudden and painful, though experiences vary. Any new or recurrent symptoms after therapy typically prompt clinical review of stored device recordings.<\/p>\n\n\n\n<p><strong>Q: How do clinicians check if the ICD is working correctly?<\/strong><br\/>\nThey use device interrogation, either in clinic or through remote monitoring, to review battery status, lead measurements, and stored rhythm episodes. The clinician also assesses symptoms, medications, and any recent hospital visits. Interpretation often focuses on whether detected events were appropriate and whether settings should be adjusted.<\/p>\n\n\n\n<p><strong>Q: Can someone with an ICD have an MRI?<\/strong><br\/>\nSome ICD systems are designed and labeled to be used under specific MRI conditions, while others may not be. Whether MRI is feasible depends on the exact device and lead system, the imaging site, and institutional protocols. This is typically coordinated between cardiology\/electrophysiology and radiology teams.<\/p>\n\n\n\n<p><strong>Q: What are \u201cinappropriate shocks,\u201d and why do they happen?<\/strong><br\/>\nAn inappropriate shock is delivered when the device mistakenly classifies a rhythm as VT\/VF or when sensing is distorted by noise or oversensing. Causes can include atrial fibrillation with rapid rates, lead problems, or sensing of non-cardiac signals. Clinicians address this through episode review, programming changes, and treatment of contributing arrhythmias.<\/p>\n\n\n\n<p><strong>Q: How long does an ICD last before it needs replacement?<\/strong><br\/>\nBattery longevity varies with pacing needs, the number of therapies delivered, and device settings. When the battery approaches end of service, the generator is typically replaced while leads may be retained if functioning well. Replacement planning is part of routine follow-up.<\/p>\n\n\n\n<p><strong>Q: Can people return to normal activities or work after ICD implantation?<\/strong><br\/>\nMany people resume usual activities over time, but the timeline and any restrictions depend on healing, underlying heart disease, and local protocols. Certain activities may be limited in the short term to allow the pocket and leads to settle. Decisions about work duties and activity level vary by clinician and case.<\/p>\n\n\n\n<p><strong>Q: What happens after an ICD is implanted\u2014what are the next steps?<\/strong><br\/>\nFollow-up commonly includes a wound check, device interrogation, and ongoing monitoring for arrhythmias and device performance. Clinicians may adjust medications, address triggers, and review any recorded events. Long-term care focuses on both device management and treatment of the underlying cardiac condition.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>An Implantable Cardioverter Defibrillator is a device placed in the body to detect and treat dangerous heart rhythms. It is a therapeutic cardiac implantable electronic device used in electrophysiology and heart failure care. It is commonly encountered when assessing risk of sudden cardiac death from ventricular arrhythmias. It may also provide pacing support in selected patients, depending on device type and programming.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-584","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=584"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/584\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}